Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4048-4052

  Fielding, Patricia ^a,b   Turnbull, Lesley ^b   Prime, Wendy ^a,b   Walshaw, Martin ^c   Field, John K ^a,b  

^a Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN;

ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; LUNG CANCER; LUNG LAVAGE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; RIBONUCLEOPROTEINS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0033396697     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Standing Medical Advisory Committee. Management of Lung Cancer. Current Clinical Practices. London: Department of Health, United Kingdom, 1994.
2. Williams, E. M. I., Youngson, J., Ashby, D., and Donnelly, R. J. Lung Cancer Bulletin - a Framework for Action. Mersey Regional Cancer Registry UK. Lung Cancer Bulletin, pp. 1-16, 1993.
3. Zhou, J., Mulshine, J. L., Unsworth, E. J., Scott, F. R., Avis, I. M., Vos, M. D., and Treston, A. M. Purification and characterisation of a protein that permits early detection of lung cancer: identification of heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for monoclonal antibody 703D4. J. Biol. Chem., 271: 10760-10766, 1996.
4. Burd, C. G., and Dreyfuss, G. RNA specificity of hnRNP A1 significance high-affinity binding sites in pre-messenger RNA splicing. EMBO J., 13: 1197-1204, 1994.
5. Montuenga, L. M., Zhou, J., Avis, I., Vos, M., Martinez, A., Cuttitta, F., Treston, A. M., Sunday, M., and Mulshine, J. L. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian development. Am. J. Respir. Cell Biol., 19: 554-562, 1998.
6. Tockman, M. S., Prabodh, K. G., Myers, J. D., Frost, J. K., Baylin, S. B., Gold, E. B., Chase, A. M., Wilkinson, P. H., and Mulshine, J. L. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol., 6: 1685-1693, 1988.
7. Tockman, M. S. Development of labels of early lung cancer at John K. Frost Centre for imaging cells and molecular markers. Lung Cancer Res. Quarterly, 1: 4-6, 1991.
8. Tockman, M. S., Gupta, P. K., Pressman, P. K., and Mulshine, J. L. Cytometric validation of immunocytochemical observations in developing lung cancer. Diagn. Cytopathol., 9: 615-622, 1993.
9. Qiao, Y. L., Taylor, P. R., Yao, S. X., Erozan, Y. S., Luo, X. C., Barrett, M. J., Yan, Q. Y., Giffen, C. A., Huang, S. Q., Maher, M. M., Forman, M. R., and Tockman, M. S. Risk factors and early detection of lung cancer in a cohort of Chinese tin miners. Ann. Epidemiol., 7: 533-541, 1997.
10. Qiao, Y-L., Tockman, M. S., Li, L., Erozan, Y. S., Yao, S-X., Barrett, M. J., Zhou, W-H., Giffen, C. A., Luo, X-C., and Taylor, P. R. A case-control study of early biomarkers of lung cancer in a screening cohort of Yunnan tin miners in China. Cancer Epidemiol. Biomark. Prev., 6: 893-900, 1997.
11. Tockman, M. S., Erozan, Y. S., Gupta, P., Piantadosi, S., Mulshine, J. L., Ruckdeschel, J. C., and the LCEDWG investigators. The early detection of second primary lung cancers by sputum immunostaining. Chest. 106 (Suppl. 6): 385s-390s. 1994.
12. Tockman, M. S., Mulshine, J. L., Piantadosi, S., Erozan, Y. S., Gupta, P. K., Ruckdeschel, J. C., Taylor, P. R., Zhukov, T., Zhou, W. H., Qiao, Y. L.. Yao, S. X. for the LCEDWG investigators and the YTC investigators. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res., 3: 2237-2246, 1997.
13. Jackobson D. R. Mutations in lung cancer. In: C. Brambilla and E. Brambilla (eds.), Lung Tumours: Fundamental Biology and Clinical Management, pp. 1139-152. New York: Marcel Dekker, 1999.
14. Slebos. R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J.. Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk. N., Mooi, W. K., Bos, J. L., and Rodenhuis, S. K.-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
15. Brambilla, E., and Gazzeri, S. p53 pathway and lung cancer. In: C. Brambilla and E. Brambilla (eds.), Lung Tumours: Fundamental Biology and Clinical Management, pp. 173-186. New York: Marcel Dekker, 1999.
16. Liloglou. T., Scholes, A. G. M., Spandidos, D. A., Vaughan, E. D., Jones, A. S., and Field, J. K. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res., 57: 4070-4074, 1997.
17. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., and Sidransky, D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA, 91: 9871-9875, 1994.
18. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
19. Wistuba, I. I., Lam, S., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Samet, J. M., Srivastava, S., Minna, J. D., and Gazdar, A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst., 89: 1366-1373, 1997.
20. Field, J. K., Liloglou, T., Xinarianos, G., Prime, W. Fielding, P., Walshaw, M. J., and Turnbull, L. Genomic alterations in bronchial lavage as a potential marker for individuals with high risk of developing lung cancer. Cancer Res., 59: 2690-2695, 1999.
21. Field, J. K. Selection and validation of new lung cancer markers for the molecular-pathological assessment of individuals with a high risk of developing lung cancer. In:. C. Brambilla and E. Brambilla (eds.), Lung Tumours: Fundamental Biology and Clinical Management, pp. 287-299. New York: Marcel Dekker, 1999.